Improvement of cerebral reperfusion by therapeutic lysis following cardiocirculatory arrest;LYSETHERAPIE ZUR VERBESSERUNG DER ZEREBRALEN REPERFUSION NACH EINEM KREISLAUFSTILLSTAND?

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie, Supplement

Volumn 32, Issue 2, 1997, Pages

  Bottiger B W ^a   Fischer, M ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Cerebral perfusion; Thrombolysis

Indexed keywords

ARTICLE; BRAIN ISCHEMIA; BRAIN PERFUSION; HEART ARREST; HUMAN; LYSIS; PATIENT MONITORING; REPERFUSION; RESUSCITATION;

ADULT; ANIMALS; BLOOD COAGULATION TESTS; BRAIN; BRAIN ISCHEMIA; CATS; HEART ARREST, INDUCED; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; INTRAOPERATIVE COMPLICATIONS; REGIONAL BLOOD FLOW; REPERFUSION INJURY; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 0030882503     PISSN: 14307790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ames A III, Wright RL, Kowada M, Thurston JM, Wagno G: Cerebral ischemia II. The no-reflow phenomenon. Am. J. Pathol. 1968;52:437-453
2. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: insight gained from studies from using markers of hemostatic system activation. Blood 1987;70:343
3. Böttiger BW: Gewebe-Plasminogenaktivator nach frustraner Reanimation bei fulminanter Lungenembolie. Deutsch. Med. Wschr. 1995;120:1528-1529
4. Böttiger BW, Böhrer H, Bach A, Motsch J, Martin E: Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation 1994; 28:45-54
5. Böttiger BW, Motsch J, Böhrer H, Böker T, Aulmann M, Nawroth PP, Martin E: Activation of blood coagulation following cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995;92:2572-2578
6. Böttiger BW, Motsch J, Böker T, Kern S, Martin E, Kirschfink M: Ausgeprägte Komplementaktivierung nach Kreislaufstillstand beim Menschen. Anaesthesist 1995;44:395
7. Böttiger BW, Reim SM, Diezel G: Erfolgreiche Behandlung einer fulminanten Lungenembolie durch hochdosierte Bolusinjektion von Urokinase während der kardiopulmonalen Reanimation. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1991;26: 29-36
8. Böttiger BW, Reim SM, Diezel G, Böhrer H, Martin E: High-dose bolus injection of urokinase. Use during cardiopulmonary resuscitation for massive pulmonary embolism. Chest 1994; 106:1281-1283
9. Böttiger BW, Schmidt H, Gust R, Böhrer H, Martin E: Successful treatment of persistent ventricular fibrillation with thrombolysis during cardiopulmonary resuscitation. Ann. Hematol. 1994;69(Suppl.2):S72
10. Brain Resuscitation Clinical Trials II Study Group: A randomized clinical study of calcium entry blocker (Lidoflazine) in the treatment of comatose survivers of cardiac arrest. N. Engl. J. Med. 1991;324:1225-1231
11. Bredbacka S, Blomback M, Wiman B, Pelzer H: Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects. Acta Anaesthesiol. Scand. 1993;37:125-130
12. Crowell JW, Sharpe GP, Lambright RL, Read WL: The mechanism of death after resuscitation following acute circulatory failure. Surgery 1955;38:696-702
13. Crowell JW, Smith EE: Effect of fibrinolytic activation on survival and cerebral damage following periods of circulatory arrest. Am. J. Physiol. 1956;186:283-285
14. Darius H, Yanagisawa A, Brezinski ME, Hock CE, Lefer AM: Beneficial effects of tissue-type plasminogen activator in acute myocardial ischemia in cats. J. Am. Coll. Cardiol. 1986;8:125
15. Dempfle CE, Dollmann M, Lill H, Puzzovio D, Dessauer A, Heene DL: Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin-chain to fibrin polymerization site "A": effects of fibrinogen and fibrinogen derivates, and pretreatment of samples with NaSCN. Blood Coag. Fibrinol. 1993;4:79-86
16. Eisenberg MS, Horwood BT, Cummins RO, Reynolds-Haertle R, Heame TR: Cardiac arrest and resuscitation: a tale of 29 cities. Ann. Emerg. Med. 1990;19:179-186
17. Eriksson M, Saldeen T: Effect of dextran on plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) during surgery. Acta Anaesthesiol. Scand. 1995;39: 163-166
18. Fischer EG, Ames A III: Studies on mechanical impairment of cerebral circulation following ischemia: Effect of hemodilution and perfusion pressure. Stroke 1972;3:538-542
19. Fischer EG, Ames A III, Hedley-White ET, O'Gorman S: Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the "no-reflow" phenomenon. Stroke 1977; 8:36-39
20. Fischer M, Böttiger BW, Popov-Cenic S, Hossmann KA: Rt-PA Lysetherapie verbessert die zerebrale Reperfusion nach Herz-Kreislaufstillstand. Anaesthesist 43;1994:817-818
21. Fischer M, Hossmann KA: Hypertonic NaCl solution reduced cerebral no-reflow after resuscitation from cardiac arrest. Anesthesiology 1993;79:A578
22. Fischer M, Hossmann KA: No-reflow after cardiac arrest. Intensive Care Med. 1995;21:132-141
23. Gaszynski W: Research work on blood clotting system during cardiopulmonary resuscitation. Anaesth. Resus. Inten. Therap. 1974;2:303-316
24. Gaszynski W: The use of protease inhibitor (Trasylol) and Heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system. Anaesth. Resus. Inten. Therap. 1975;3:125-134
25. Ginsberg MD, Myers RE: The topography of impaired microvascular reperfusion in the primate brain following total circulatory arrest. Neurology 1972;22:998-1011
26. Gramann J, Lange-Braun P, Bodemann T, Hochrein H: Einsatzmöglichketten der Thrombolyse in der Reanimation. Intensivmed. 1988;25:425-429
27. Greenberg CS, Devine DV, McCrae KM: Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads. Am. J. Clin. Pathol. 1987;87:94-100
28. Haft JI, Kranz PD, Albert FJ, Fani K: Intravascular platelet aggregation in the heart induced by norepinephrine. Circulation 1972;46:698-708
29. Hartveit F, Halleraker B: Intravascular changes in kidneys and lungs after external cardiac massage: A preliminary report. J. Pathol. 1970;102:54-58
30. Hekmatpanah J: Cerebral blood flow dynamics in hypotension and cardiac arrest. Neurology 1973;23:174-180
31. Hoek JA, Sturk A, ten Cate JW, Lamping RJ, Berends F, Borm JJJ: Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. Clin. Chem. 1988;34: 2058-2062
32. Hossmann KA: Ischemia-mediated neuronal injury. Resuscitation 1993;26:225-235
33. Hossmann KA: Resuscitation potentials after prolonged global cerebral ischemia in cats. Crit. Care Med. 1988;16:964-971
34. Hossmann KA, Schmidt-Kastner R, Grosse-Ophoff B: Recovery of integrative central nervous function after one hour global cerebro-circulatory arrest in normothermic cat. J. Neurol. Sci. 1987;77:305-320
35. Iijima T, Nakamura Z, Ishii H, Saito I, Sankawa H: Effect of thromboxane synthetase inhibitor on delayed neuronal death after global ischemia. Anesthesiology 1994;81(3A):A850
36. Jerome SN, Doré M, Paulson JC, Smith CW, Korthuis RJ: P-Selectin and ICAM-1-dependant adherence reactions: role in the genesis of postischemic no-reflow. Am. J. Physiol. 1994;266: H1316
37. Larsson PT, Wallén NH, Hjemdahl P: Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 1994;89:1951-1957
38. Latour JG, McKay DG, Parrish MH: Activation of Hageman factor by cardiac arrest. Thromb. Diathes. Haemorrh. 1972;3:543-553
39. Lin SR, O'Connor MJ, Fischer HW, King A: The effect of combined Dextran and streptokinase on cerebral function and blood flow after cardiac arrest: an experimental study on the dog. Invest. Radiol. 1978;13:490-498
40. McKay DG, Latour JG, Parrish MH: Activation of Hageman factor by α-adrenergic stimulation. Thrombos. Diathes. Haemorrh. 1970;23:417-422
41. Mori E, Del Zoppo GJ, Chambers JD, Copeland BR, Arfors KE: Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992;23:712-718
42. Mossakowski MJ, Lossinsky AS, Pluta R, Wisniewski HM: Changes in cerebral microcirculation system following experimentally induced cardiac arrest, an SEM and TEM Study. In: Tomita M, Mchedlishvili G, Rosenblum W, Heiss WD, Fukuuchi Y (Eds.): Microcirculatory stasis in the brain. Excerpta Medica, Amsterdam, London, New York 1993, pp. 99-106
43. Rosenfeld BA, Faraday N, Campbell D, Dise K, Bell W, Goldschmidt P: Hemostatic effects of stress hormone infusion. Anesthesiology 1994;81:1116-1126
44. Safar P: Cerebral resuscitation after cardiac arrest: A review. Circulation 1986:74(Suppl.4):138-153
45. Safar P, Stezoski SW, Nemoto EM: Amelioration of brain damage after 12 minutes cardiac arrest in dogs. Arch. Neurol. 1976;33: 91-95
46. Scholz KH, Tebbe U, Herrmann C, Wojcik J, Lingen R, Chemnitius JM, Brune S, Kreuzer H: Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am. J. Cardiol. 1992;69:724-728
47. Seo K, Ishimaru S, Hossmann KA: Two-stage resuscitation of the cat brain after prolonged cardiac arrest. Intensive Care Med. 1991;17:410-418
48. Tanahashi N, Fukuuchi Y, Tomita M, Kobari M, Shinohara T, Yamawaki T, Konno S, Takeda H: Platelet-activating factor antagonist (TCV-309) ameliorates postischemic delayed hypoperfusion after 30s cardiac arrest in cats. In: Tomita M, Mchedlishvili G, Rosenblum W, Heiss WD, Fukuuchi Y (Eds.): Microcirculatory stasis in the brain. Excerpta Medica, Amsterdam, London, New York 1993, pp. 203-210
49. Tenagha AN, Califf RM, Candela RJ, Kereiakes DJ, Berrios E, Young SY, Stack RS, Topol EJ: Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am. J. Cardiol. 1991;68:1015